Cell Signaling Technology

Product Pathways - Growth Factors/Cytokines

Human Transforming Growth Factor β1 (hTGF-β1) #8915

TGF beta-1   TGF-b   TGF-beta   TGFb   TGFb1   TGFbeta   tgfbeta1  

No. Size Price
8915LC 10 µg ( With Carrier ) ¥2,580.00 现货查询 购买询价
8915LF 10 µg ( Carrier Free ) ¥2,580.00 现货查询 购买询价
8915 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype

Species cross-reactivity is determined by western blot.

Applications Key:

Source / Purification

Recombinant human TGF-β1 (hTGF-β1) Ala279-Ser390 (Accession #P01137) was expressed in human 293 cells at Cell Signaling Technology.

重组人源蛋白TGF-β1 (hTGF-β1)丙氨酸279-丝氨酸390(编号P01137)表达于Cell Signaling Technology公司的人293细胞中。

Molecular Characterization

Recombinant hTGF-β1 contains no "tags" and the nonglycosylated protein has a calculated MW of 12,794. DTT-reduced protein migrates as a 13 kDa polypeptide and the non-reduced cystine-linked homodimer migrates as a 25 kDa protein. The expected amino-terminal ALDTN of recombinant hTGF-β1 was verified by amino acid sequencing.人源重组TGF- β1不含标签蛋白这种非糖基化蛋白分子量为12794,DTT还原蛋白为13kDa多肽,未还原的由胱氨酸连接而成的二聚体分子量为25kDa。人源重组TGF- β1的预期N-氨基末端的ALDTN由氨基酸测序验证。

Purity

>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hTGF-β1. Less than 1% migrates as monomer hTGF-β1 under non-reduced (-) conditions. All lots are greater than 98% pure.6 μg还原和未还原的人源重组TGF-β1由SDS-PAGE测定纯度大于98%,在非还原条件下少于1%游离物hTGF-β1以单体形式存在。所有批次的产品纯度均大于98%。

Bioactivity

The bioactivity of recombinant hTGF-β1 was determined by assessing inhibition of IL-4 induced HT-2 cell proliferation. The ED50 of each lot is between 0.04-0.20 ng/ml.通过评估由抑制IL-4诱导的HT-2细胞的增殖来测定人源重组TGF- β1的生物活性。其每个批次的ED50在 0.04-0.20 ng/ml之间。

Coomassie Gel

Coomassie Gel

The purity of recombinant hTGF-β1 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hTGF-β1 and staining overnight with Coomassie Blue.hTGF-β1 纯度用SDS-PAGE检验,6 µg 还原(-)和未还原(-)重组hFGF basic 电泳后考马斯蓝染色过夜。

Bioactivity

Bioactivity

The inhibition of IL-4 induced proliferation in HT-2 cells treated with increasing concentrations of hTGF-β1 was assessed. After 48 hour treatment with hTGF-β1, cells were incubated with a tetrazolium salt and the OD450 - OD650 was determined.检验浓度逐渐增长的 hTGF-β1 对IL-4诱导的HT-2细胞增殖的抑制能力。hTGF-β1处理48小时候,细胞用一种四唑盐孵育,并检测OD450 - OD650 吸光值。

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells, untreated or treated with hTGF-β1 for 25 minutes, using Phospho-Smad2 (Ser465/467) (138D4) Rabbit mAb #3108 (upper) and Smad2 (86F7) Rabbit mAb #3122 (lower).用Phospho-Smad2 (Ser465/467) (138D4) 兔单抗#3108 (上)和 Smad2 (86F7) 兔单抗#3122 (下) 对未处理或经过hTGF-β1 处理25分钟的HeLa细胞提取物进行western blot分析。.

Endotoxin

Less than 0.01 ng endotoxin/1 μg hTGF-β1.每1 μg hTGF-β1中内毒素含量低于0.01ng

Formulation

With carrier: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl and 20 μg BSA per 1 μg hTGF-β1. Carrier free: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl.每1 μg hTGF-β1溶于含有20 mM柠檬酸盐、100mM氯化钠、20 μgBSA、pH3.0的经0.22 μm滤器过滤的溶液后冻干带有载体。经0.22 μm滤器过滤的20 mM柠檬酸盐、100mM氯化钠、pH3.0的溶液的冻干物无载体。

Background

TGF-β1 activities include proliferation, angiogenesis and promotion or inhibition of many immune events (1-3). TGF-β1 is produced by a number of cell types including regulatory T cells, fibroblasts, epithelial cells, and endothelial cells (3). TGF-β1 binds to TβRII homodimer, which then complexes with TβRI homodimer (1,4). The oligomeric receptor complex phosphorylates subsets of the SMAD proteins that then act to induce and repress a number of target genes (1,3,4). TGF-β1 binding can also activate the Erk2, p38, and JNK pathways via TAK1 (4). TGF-β1 appears to promote late stage progression and metastasis in some cancers (1,2).

TGF-β1能激活包括增殖、血管生成和促进或抑制免疫在内的各种反应[1-3]。TGF-β1由各种细胞产生,包括调控性T淋巴细胞、成纤维细胞、上皮细胞和内皮细胞[3]。TGF-β1与TβRII二聚体结合形成复合体后又与TβRI二聚体结合[1,4]。此低聚物受体复合物磷酸化Smad蛋白小分子集团后能诱导或抑制一系列基因靶标[1,3,4]。TGF-β1的结合也可通过TAK1激活Erk2, p38和JNK 通路[4]。TGF-β1还被发现在促进某些癌症晚期转移和进展[1,2]。

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products


For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0

该产品暂无评论!

我要参与评论 :

如要参与评论请先登录网站

还没有网站账户?去注册一下吧

Products

 

Applications